LACK OF ACIPIMOX DIGOXIN INTERACTION IN PATIENT VOLUNTEERS

被引:0
|
作者
CHIJIOKE, CP [1 ]
PEARSON, RM [1 ]
BENEDETTI, S [1 ]
机构
[1] ST BARTHOLOMEWS HOSP, DEPT CLIN PHARMACOL, LONDON EC1A 7BE, ENGLAND
关键词
D O I
10.1177/096032719201100509
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
1 A study was carried out to find out if digoxin and acipimox interact. 2 Six elderly patients on digoxin were each given acipimox 150 mg three daily for a week, after informed consent. Digoxin and acipimox plasma concentrations and urinary excretion were measured after the first dose of acipimox and after a week of treatment 3 Data were fitted to a one-compartment oral absorption model. Areas under the plasma concentration-time curve, plasma and renal clearances, and elimination half-life were computed. 4 There was no significant difference in digoxin plasma concentrations and kinetic parameters before and after acipimox administration. Acipimox kinetics were not affected by the concomitant ingestion of digoxin. 5 The patients' clinical condition remained stable during the study. 6 Thus there was no evidence for an adverse interaction between digoxin and acipimox in human subjects under the conditions of this study.
引用
收藏
页码:357 / 359
页数:3
相关论文
共 50 条
  • [1] EFFECT OF ACIPIMOX ON PLASMA DIGOXIN LEVELS IN ELDERLY PATIENT VOLUNTEERS
    CHIJIOKE, PC
    PEARSON, RM
    JOHNSTON, A
    BLACKETT, A
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 25 (01) : P102 - P103
  • [2] LACK OF INTERACTION BETWEEN ZACOPRIDE AND DIGOXIN IN HEALTHY-VOLUNTEERS
    KAHAN, A
    PINQUIER, JL
    DELAUTURE, D
    PERLES, P
    COPIE, X
    LETRAIT, M
    STALLABOURDILLON, A
    WEBER, S
    STRAUCH, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (02) : 229 - 229
  • [3] Lack of pharmacokinetic interaction between gemifloxacin and digoxin in healthy elderly volunteers
    Vousden, M
    Allen, A
    Lewis, A
    Ehren, N
    CHEMOTHERAPY, 1999, 45 (06) : 485 - 490
  • [4] Nateglinide, a new mealtime glucose regulator - Lack of pharmacokinetic interaction with digoxin in healthy volunteers
    Zhou, HH
    Walter, YH
    Smith, H
    Devineni, D
    McLeod, JF
    CLINICAL DRUG INVESTIGATION, 2000, 19 (06) : 465 - 471
  • [5] Lack of clinically significant interaction between steady state tolvaptan and digoxin in healthy volunteers.
    Shoaf, SE
    Wang, Z
    Mallikaarjun, S
    Bricmont, P
    Bramer, SL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P37 - P37
  • [6] Lack of kinetic interaction between digoxin and voglibose
    Kusumoto, M
    Ueno, K
    Fujimura, Y
    Kameda, T
    Mashimo, K
    Takeda, K
    Tatami, R
    Shibakawa, M
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 55 (01) : 79 - 80
  • [7] Lack of kinetic interaction between digoxin and voglibose
    M. Kusumoto
    K. Ueno
    Y. Fujimura
    T. Kameda
    K. Mashimo
    K. Takeda
    R. Tatami
    M. Shibakawa
    European Journal of Clinical Pharmacology, 1999, 55 : 79 - 80
  • [8] A pharmacokinetic interaction study of ticagrelor and digoxin in healthy volunteers
    Teng, Renli
    Butler, Kathleen
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (10) : 1801 - 1808
  • [9] Absence of interaction of fondaparinux sodium with digoxin in healthy volunteers
    Mant, T
    Fournié, P
    Ollier, C
    Donat, F
    Necciari, J
    CLINICAL PHARMACOKINETICS, 2002, 41 (Suppl 2) : 39 - 45
  • [10] No interaction between nebivolol and digoxin in healthy volunteers.
    Lawrence, TE
    Liu, S
    Fisher, JW
    Vukic-Bugarski, T
    Donnelly, CM
    Huang, MY
    Rackley, RJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P76 - P76